HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer (Q41308137)

29 September 2017

HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer (English)

1 reference

29 September 2017

1 reference

13

1 reference

29 September 2017

16

1 reference

29 September 2017

Khawla Al-Kuraya

1

1 reference

29 September 2017

Hedvika Novotny

2

1 reference

29 September 2017

Prashant Bavi

3

1 reference

29 September 2017

Abdul K Siraj

4

1 reference

29 September 2017

Shahab Uddin

5

1 reference

29 September 2017

Adnan Ezzat

6

1 reference

29 September 2017

Nasser Al Sanea

7

1 reference

29 September 2017

Fouad Al-Dayel

8

1 reference

29 September 2017

Hadeel Al-Mana

9

1 reference

29 September 2017

Salwa S Sheikh

10

1 reference

29 September 2017

Martina Mirlacher

11

1 reference

29 September 2017

Coya Tapia

12

1 reference

29 September 2017

Guido Sauter

14

1 reference

29 September 2017

Luigi Terracciano

15

1 reference

29 September 2017

language of work or name

English

0 references

publication date

1 August 2006

1 reference

Journal of Clinical Pathology

29 September 2017

1 reference

29 September 2017

60

1 reference

29 September 2017

7

1 reference

29 September 2017

768-772

1 reference

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995777

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995777

Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995777

Tissue microarrays in drug discovery

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995777

Chromosomal imbalances in the colorectal carcinomas with microsatellite instability

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995777

Diet, Body Weight, and Colorectal Cancer: A Summary of the Epidemiologic Evidence

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995777

Interethnic difference in the allelic distribution of human epidermal growth factor receptor intron 1 polymorphism.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995777

Smart drugs: tyrosine kinase inhibitors in cancer therapy

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995777

c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995777

High frequency of p53 gene mutations in primary breast cancers in Japanese women, a low-incidence population

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995777

Intake of fat, meat, and fiber in relation to risk of colon cancer in men.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995777

A prospective study of dietary fat and risk of prostate cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995777

Novel pattern of P53 mutation in breast cancers from Austrian women.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995777

Incidence of chromosomal imbalances in advanced colorectal carcinomas and their metastases.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995777

Tissue microarrays for gene amplification surveys in many different tumor types.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995777

Evaluation of myc and chromosome 8 copy number in colorectal cancer using interphase cytogenetics

19 August 2018

1 reference

12 December 2020

Predominance of high-grade pathway in breast cancer development of Middle East women

1 reference

12 December 2020

Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer

1 reference

12 December 2020

Recurrent genetic alterations in 26 colorectal carcinomas and 21 adenomas from Chinese patients

1 reference

12 December 2020

Aggressive subtypes of human colorectal tumors frequently exhibit amplification of the c-myc gene

1 reference

12 December 2020

Low-level c-myc amplification in human colonic carcinoma cell lines and tumors: a frequent, p53-independent mutation associated with improved outcome in a randomized multi-institutional trial

1 reference

12 December 2020

Identifiers

DOI

10.1136/JCP.2006.038281

1 reference

29 September 2017

1 reference

29 September 2017

1 reference